Anzeige
Mehr »
Dienstag, 11.08.2026 - Börsentäglich über 12.000 News

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Renaissance Capital

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
MiSPAC Gravity Acquisition files for a $250 million IPO, targeting North America, Europe, and Asia
MiSPAC TCGX Acquisition prices $75 million IPO, targeting healthcare in Asia
MiImmune-focused biotech Attovia Therapeutics prices previously upsized IPO at $17, as expected
04.08.Luminous Acquisition, a SPAC led by an ARC Group executive, files for a $105 million IPO
04.08.Renaissance Capital's July IPO Market Update
04.08.Immune-focused biotech Attovia Therapeutics ups deal size by 45%, sets proposed price at $17 ahead of $289 million IPO
04.08.SPAC BOA Acquisition II prices $125 million IPO, targeting real estate and infrastructure
04.08.SPAC ARC Group Securities Acquisition I prices $105 million IPO, led by ARC Group executives
03.08.SPAC 1776 Acquisition files for a $150 million IPO, targeting tech-enabled businesses
03.08.Hong Kong-based nutrition products Fitness Fanatics more than triples shares offered ahead of $35 million US IPO
03.08.SPAC East West Ave Acquisition prices $100 million IPO, targeting fintech, digital assets, and energy
03.08.SPAC GX Acquisition III files for a $200 million IPO, targeting advanced computing
03.08.Chinese copper foils producer Londian Wason New Energy Tech sets terms for $75 million US IPO
03.08.Pain relief biotech Latigo Biotherapeutics sets terms for $272 million IPO
03.08.Cancer biotech BlossomHill Therapeutics sets terms for $125 million IPO
01.08.US IPO Week Ahead: August IPO market opens with biotechs, a bank, and SpaceX earnings
01.08.US IPO Weekly Recap: Jersey Mike's and Reformation underwhelm
31.07.Nuclear microreactor developer Nuclea Energy withdraws $50 million US IPO
31.07.Michael Klein's latest SPAC Churchill Capital Corp XIII prices upsized $360 million IPO
31.07.Sleep apnea pill developer Apnimed prices upsized IPO at $16, the high end of the range
30.07.Golf shot tracking platform Game Your Game completes Nasdaq direct listing on Thursday, 7/30
30.07.Cardiovascular diseases biotech Braveheart Bio sets terms for $300 million IPO
30.07.Blackstone-backed sandwich chain Jersey Mike's Subs prices IPO at the $23 midpoint
30.07.Womenswear brand Reformation prices IPO at $15, the low end of the range
30.07.Metabolic disorders biotech Vogenx sets terms for $75 million IPO